Abstract
Although morbility and mortality in acromegaly are higher than in the general population, there have been very few previous epidemiological studies. This study tries to answer “why”. Seventy-four patients affected by acromegaly in Vizcaya (Spain) between 1970 and 1989 were considered for an epidemiological study. The prevalence of known cases at the end of 1989 was 60 per million inhabitants. The average incidence of newly diagnosed cases was 3.1 per million people per year. Unexpectedly, acromegaly was more frequent in women (n=48) than in men (n=26), with a ratio of 1.8:1. Mean age at diagnosis was significantly higher in women (46.1 ±2.2 yr) than in men (39.5+2.2 yr) (p<0.05) There was a positive correlation between age at diagnosis and the estimated duration of the disease (r=0.56, p<0.05) and a negative one between age and basal GH serum levels (r=−0.52 p<0.002). The age at diagnosis was significantly higher in patients with invasive tumors (grade III and IV) than in those with enclosed tumors (grade I and II) (47.7+1.8 vs 40.1±3.3 p<0.05). In general, mortality was higher than the expected for the control population (standardized mortality ratio, SMR=3.2, 95% confidence Interval. CI=1.55–5.93). However, mortality was higher in men (SMR=7, 95% Cl=2.81–14.4) but not in women (SMR=1.4 95% Cl=0.29–4.17). Concerning the cause of death in men, the SMR of vascular disease was 10 (95% Cl=0.25–55.7) and the SMR of malignant neoplasms was 7.1 (95% Cl=2.31–16.6). In conclusion prevalence and incidence of acromegaly were similar to those previously reported except that we observed a higher prevalence, in women. Mortality was higher in men, due particularly to vascular and neoplastic causes.
Similar content being viewed by others
References
Lawrence J.H., Tobias C.A., Linfoot J.A., Born J.L., Lyman J.T., Chong C.Y., Manougian E., Wei W.C. Successful treatment of acromegaly: Metabolic and clinical studies in 145 patients. J. Clin. Endocrinol. Metab. 31: 180, 1970.
Nabarro J.D.N. Acromegaly. Clin. Endocrinol. (Oxf.) 26: 481, 1987.
Alexander L., Appleton D., Hall R., Ross W.M., Wilkinson R. Epidemiology of acromegaly in the Newcastle region. Clin. Endocrinol. (Oxf.) 72: 71, 1980.
Bengtsson B., Eden S., Ernest I., Oden A., Sjogren B. Epidemiology and long-term survival in acromegaly. A study of 166 cases diagnosed between 1955 and 1984. Acta Med. Scand. 223: 327, 1988.
Ritchie C.M., Atkinson A.B., Kennedy A.L., Lyons A.R., Gordon D.S., Fannin T., Hadden D.R. Ascertainment and natural history of treated acro megaly in Northern Ireland. Ulster Med. J. 59: 55, 1990.
Wright A.D., Hill D.M., Lowy C., Fraser T.R. Mortality in acromegaly. Q.J. Med. 39: 1, 1970.
World Health Organization. Arterial hypertension. WHO Tech. Rep. Ser. 628, 1978.
World Health Organization. Diabetes Mellitus. WHO Tech. Rep. Ser. 727, 1985.
Guiot G. Transsphenoidal approach in surgical treatment of pituitary adenoma. General principles and indications in non functioning adenomas. In: Kohler P.O., Ross G.T. (Eds.), Diagnosis and Treatment of Pituitary Tumors. Excerpta Medica, Amsterdam, 1973, p. 159.
Vezina J.L, Maltais R. La selle turcique dans l’acromegalic. Etude radiologique. Neurochirurgie 19 (Suppl. 2): 35, 1973.
Carrasco J.L. El método estadístico en la investigacion medica, ed. 2. Editorial Ciencia 3, Madrid, 1986.
Matthews D.E., Farewell V.T. Estadística médica. Aplicacion e interpretacion, ed. Salvat, Mallorca, 1990.
Publicacion del sistema vasco de informacion sani taria. La mortalidad en la Comunidad Autonoma del Pais Vasco, 1987. SISVA 6, 1989.
Breslow N.E., Day N.E. Statistical methods in cancer research. Vol 2. The design of cohort studies. I.A.R.C. Sci. Pub. 82: 1987.
Balagura S., Derome P., Guiot G. Acromegaly: analysis of 132 cases treated surgically. Neurosurgery 8: 413, 1981.
Melmed S. Acromegaly. N. Engl. J. Med. 322: 966, 1990.
Jadresic A., Banks L.M., Child D.F., Diamant L., Doyle F.H., Fraser T.R., Joplin G.F. The acromegaly syndrome: relation between clinical feature, growth hormone values and radiological characteristics of the pituitary tumors. Q.J. Med. 202: 189, 1982.
Grisoli F., Leclerq T., Jaquet P., Guibout M., Winteler J., Hassoun J., Vincentelli F. Transsphnoidal surgery for acromegaly. Long-term results in 100 patients. Surg. Neurol. 23: 513, 1985.
Thorner M.O., Frohman L.A., Leong D.A., Thominet J., Downs T., Hellmann P., Chitwood J., Vaughan J.M., Vale W. Extrahypotalamic growth-hormone-releasing factor (GRF) secretion is a rare cause of acromegaly: plasma GRF levels in 177 acromegalic patients. J. Clin. Endocrinol. Metab. 59: 846, 1984.
Martino I., Winteler J.P., Costa R., Jeanjean M.E., Grisoli F., Jaquet P. Les traitements de l’acromegalie. Rev. Fr. Endocrinol. Clin. 28: 263, 1987.
Baskin D.S., Boggan J.E., Wilson C.B. Transsphenoidal microsurgical removal of growth hormone-secreting pituitary adenomas. A review of 137 cases. J. Neurosurg. 56: 634, 1982.
Quabbe H.J. Treatment of acromegaly by transsphenoidal operation, 90-Yttrium implantation and bromocriptine: results in 230 patients. Clin. Endocrinol. (Oxf.) 16: 107, 1982.
Serri O., Robert F., Comtois R., Jilwan N., Beauregard H., Hardy J., Somma M. Distinctive features of prolactin secretion in acromegalic patients with hyperprolactinaemia. Clin. Endocrinol. (Oxf.) 27: 429, 1987.
Ross D.A., Wilson C.H. Results of transsphenoidal microsurgery for growth hormone-secreting pituitary adenoma in a series of 214 patients. J. Neurosurg. 68: 854, 1988.
Barcelo B., Perez C., Davila N., Lucast Salto L., Alcañiz J. Valoración endocrinológica de 61 pacientes acromegálicos tratados con cirugia transesfenoidal aislada o asociada a telecobaltoterapia y/o bromocriptina. Med. Clin. 80: 735, 1983.
Del Pozo C., Weeb S.M., Oliver B. Tresserras P., De Leiva A. Tratamiento de la acromegalia. Resultados en 56 pacientes. Med. Clin. 94: 85, 1990.
Gold E.B. Epidemiology of pituitary adenomas. Epidemiol. Rev. 3: 163, 1981.
Kanis A., Guillingham F.J., Harris P., Horn D.B., Hunter W.M., Redpath A.T., Strong J.A. Clinical and laboratory study of acromegaly: Assesment before and one year after treatment. Q.J. Med. 43: 409, 1974.
Blumberg D.L., Sklar C.A., David R., Rothenberg S., Bell J. Acromegaly in an infant. Pediatrics 83: 998, 1989.
Klijn J.G.M., Lamberts S.W.J., De Jong F.H., Van Dongen K.J., Birkenhäger J.C. Interrelationships between tumor size, age, plasma growth hormone and incidence of extrasellar extension in acromegalic patients. Acta Endocrinol. (Copenh.) 95: 289, 1980.
Roelfsema F., Van Dulken H., Frölich M. Longterm results of transsphenoidal pituitary mi crosurgery in 60 acromegalic patients. Clin. Endocrinol. (Oxf.) 23: 555, 1985.
Lieberman S.A., Hoffman A.R. Sequelae to acromegaly: Reversibility with treatment of the primary disease. Horm. Metab. Res. 22: 313, 1990.
McGuffin W.L., Sherman B.M., Roth J., Gorden P., Kahn R., Roberts W.C., Frommer P.L. Acromegaly and cardiovascular disorders: a pro spective study. Ann. Intern. Med. 37: 11, 1974
Fraser R., Davies D.L., Connell J.M.C. Hormones and hypertension. Clin. Endocrinol. (Oxf.) 37: 701, 1989.
Smals A.E., Pieters G.F., Smals A.G., Kloppenborg P.W. Sex difference in the relation between sellar volume and basal and GH-releasing hormone stimulated GH in acromegaly. Acta Endocrinol. (Copenh.) 11: 387, 1988.
U.S.H., Wilson C.B., Tyrrel J.B. Transsphenoidal microhypophisectomy in acromegally. J. Neurosurg. 47: 840, 1977.
Wass J.A.H., Cudworth A.G., Bottazzo G.F., Woodrow J.C., Besser G.M. An assesment of glucose intolerance in acromegaly and its response to medical treatment. Clin. Endocrinol. (Oxf.) 72: 53, 1980.
Bjerre P., Lindholm J., Videbaek H. The spontaneous course of pituitary adenomas and occurrence of an empty sella in untreated acromegaly. J. Clin. Endocrinol. Metab. 63: 287, 1986.
Werner P.L., Shah J.H., Kukreja S.C., Miller S.M., Williams G.A. Recurrence of acromegaly after pituitary apoplexy. JAMA 247: 2816, 1982.
Klein I., Parveen G., Gavaler J.S., Vanthiel D.H. Colon polyps in patients with acromegaly. Ann. Intern. Med. 97: 27, 1982.
Ituarte E.A., Petrini J., Hershman J.M. Acromegaly and colon cancer. Ann. Intern. Med. 101: 627, 1984.
Pines A., Rozen P., Ron E., Gilat T. Gastrointestinal tumors in acromegalic patients. Am. J. Gastroenterol. 80: 266, 1985.
Brunner J.E., Johnson C.C., Zafar S., Peterson E.L., Brunner J.F., Mellinger R.C. Colon cancer and polyps in acromegaly: increased risk associated with family hystory of colon cancer. Clin. Endocrinol. (Oxf.) 32: 65, 1990.
Ezzat S., Strom C., Melmed S. Colon polips in acromegaly. Ann. Intern. Med. 114: 754, 1991.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Etxabe, J., Gaztambide, S., Latorre, P. et al. Acromegaly: An epidemiological study. J Endocrinol Invest 16, 181–187 (1993). https://doi.org/10.1007/BF03344942
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/BF03344942